Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 2

Status

Active not recruiting 3Recruiting 2

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 5

Conditions

Squamous Cell Carcinoma of Head and Neck 16Oropharyngeal Neoplasms 10Nasopharyngeal Carcinoma 10Prostatic Neoplasms 7Laryngeal Neoplasms 6Rectal Neoplasms 5Mouth Neoplasms 5Hypopharyngeal Neoplasms 5Head and Neck Neoplasms 5Carcinoma 5Carcinoma, Non-Small-Cell Lung 4Esophageal Neoplasms 3Carcinoma, Squamous Cell 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Urinary Bladder Neoplasms 2Salivary Gland Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Nasopharyngeal Neoplasms 2Mesothelioma 2Epstein-Barr Virus Infections 2Carcinoma, Intraductal, Noninfiltrating 2Astrocytoma 2Anus Neoplasms 2Vaginal Neoplasms 1Urothelial Carcinoma of the Bladder 1Tongue Neoplasms 1Thyroid Carcinoma, Anaplastic 1Stomatitis 1Stomach Neoplasms 1

Interventions

Capecitabine 23Oxaliplatin 21Fluorouracil 16Radiotherapy 11Leucovorin 10Cetuximab 9Nivolumab 7Bevacizumab 7Surgical Procedures, Operative 5Specimen Handling 5Radiotherapy, Intensity-Modulated 5Magnetic Resonance Spectroscopy 5Irinotecan 5Folfox protocol 5trifluridine tipiracil drug combination 4sintilimab 4pembrolizumab 4encorafenib 3X-Rays 3Trastuzumab 3Surveys and Questionnaires 3Sigmoidoscopy 3Radiation 3Pemetrexed 3Gemcitabine 3Endoscopy 3Control Groups 3Consolidation Chemotherapy 3Cisplatin 3Chemoradiotherapy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Rectal Neoplasms × Radiotherapy, Intensity-Modulated × 90 days × Clear all
NCT04165772 2026-05-13

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
212 enrolled
Gastrointestinal

Rectal Neoplasms

NCT04929028 2026-05-13

Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer

National Cancer Institute (NCI)

Phase 2 Active not recruiting
40 enrolled
Gastrointestinal

Anus Neoplasms, Rectal Neoplasms, HIV Infections

NCT04104139 2026-04-15

TAS-102 With Concurrent Radiation for the Treatment of Untreated Resectable Stage II-III Rectal Cancer

OHSU Knight Cancer Institute

Phase 1 Active not recruiting
19 enrolled
Gastrointestinal

Rectal Neoplasms

NCT02381561 2026-04-13

Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy

National Cancer Institute (NCI)

Phase 1 Active not recruiting
19 enrolled
Gastrointestinal

Colonic Neoplasms, Esophageal Neoplasms, Liver Neoplasms, Rectal Neoplasms, Stomach Neoplasms

NCT04703101 2026-03-30

Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer

Jonsson Comprehensive Cancer Center

Phase 1 Recruiting
25 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡